VasotropeAlternative Names: HN 10200
Latest Information Update: 08 Sep 2006
At a glance
- Originator Amersham
- Class Cardiotonics; Vasodilators
- Mechanism of Action Phosphoric diester hydrolase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 08 Sep 2006 Discontinued - Phase-II for Heart failure in Norway (unspecified route)